Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
Clinical trial NCT01938430 · COMPLETED
Trial details
- NCT number
- NCT01938430
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-01-01
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.